Furthermore, in a single-cell RNA-Seq (scRNA-Seq) analysis, we observed that FCGR2B is mainly expressed in tumor-associated macrophages (TAMs) and dendritic cells (DCs) and is preferentially expressed in recurrent GBM. This evidence concerns the gene FCGR2B and neoplasm.